| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |